JPH08510731A - 治療使用のためのその場で生成するゲル - Google Patents

治療使用のためのその場で生成するゲル

Info

Publication number
JPH08510731A
JPH08510731A JP7500555A JP50055595A JPH08510731A JP H08510731 A JPH08510731 A JP H08510731A JP 7500555 A JP7500555 A JP 7500555A JP 50055595 A JP50055595 A JP 50055595A JP H08510731 A JPH08510731 A JP H08510731A
Authority
JP
Japan
Prior art keywords
composition according
composition
mos
drug
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7500555A
Other languages
English (en)
Japanese (ja)
Inventor
カールフオルス，ヨーハン
エドスマン，カタリーナ
Original Assignee
フアーマシア・アクチエボラーグ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by フアーマシア・アクチエボラーグ filed Critical フアーマシア・アクチエボラーグ
Publication of JPH08510731A publication Critical patent/JPH08510731A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP7500555A 1993-06-02 1994-06-01 治療使用のためのその場で生成するゲル Pending JPH08510731A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9301877A SE9301877D0 (sv) 1993-06-02 1993-06-02 In situ gel for therapeutic use
SE9301877-8 1993-06-02
PCT/SE1994/000522 WO1994027578A1 (en) 1993-06-02 1994-06-01 In situ gel for therapeutic use

Publications (1)

Publication Number Publication Date
JPH08510731A true JPH08510731A (ja) 1996-11-12

Family

ID=20390132

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7500555A Pending JPH08510731A (ja) 1993-06-02 1994-06-01 治療使用のためのその場で生成するゲル

Country Status (6)

Country Link
EP (1) EP0706372A1 (de)
JP (1) JPH08510731A (de)
AU (1) AU6940594A (de)
CA (1) CA2164113A1 (de)
SE (1) SE9301877D0 (de)
WO (1) WO1994027578A1 (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004189731A (ja) * 2002-11-26 2004-07-08 Taisho Pharmaceut Co Ltd 点鼻剤
JP2009073828A (ja) * 2007-08-30 2009-04-09 Taisho Pharmaceutical Co Ltd 点眼剤
US8216604B2 (en) 2003-01-10 2012-07-10 Archimedes Development Limited Method of managing or treating pain

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2746014B1 (fr) * 1996-03-13 1999-01-08 Composition ophtalmologique du type subissant une transition de phase liquide-gel
CA2248881A1 (en) * 1996-03-13 1997-09-18 Annouk Rozier Ophthalmological composition of the type which undergoes liquid-gel phase transition
FR2754712B1 (fr) * 1996-10-17 1999-09-03 Merck Sharp Dohme Chibret Lab Compositions ophtalmiques
CA2273206A1 (en) * 1996-11-29 1998-06-04 Monsanto Company Lubricious self-standing (intact) gel for oral delivery of biologically-active ingredients
DE102010023949A1 (de) * 2010-06-16 2011-12-22 F. Holzer Gmbh In-situ Lecithin-Mikroemulsionsgel-Formulierung
US10568975B2 (en) 2013-02-05 2020-02-25 The Johns Hopkins University Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
EP3233098B1 (de) 2014-12-15 2024-05-29 The Johns Hopkins University Cvs-transplantation zur behandlung von bakterieller vaginose
KR20240126072A (ko) 2015-01-27 2024-08-20 더 존스 홉킨스 유니버시티 점막표면에서 활성제의 향상된 수송을 위한 저장성 하이드로겔 제제
CN109260146A (zh) * 2018-10-12 2019-01-25 广州大光制药有限公司 地夸磷索钠眼用即用型凝胶滴眼液及制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
FR2657018A1 (fr) * 1990-01-12 1991-07-19 Merck Sharp & Dohme Composition ophtalmique fluide a base de microparticules lipidiques contenant au moins un principe actif et son procede de preparation.
CA2040460C (en) * 1990-05-01 1997-06-10 Tacey X. Viegas Drug delivery with thermoreversible gels
JP2594486B2 (ja) * 1991-01-15 1997-03-26 アルコン ラボラトリーズ インコーポレイテッド 局所的眼薬組成物

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004189731A (ja) * 2002-11-26 2004-07-08 Taisho Pharmaceut Co Ltd 点鼻剤
US8216604B2 (en) 2003-01-10 2012-07-10 Archimedes Development Limited Method of managing or treating pain
US8889176B2 (en) 2003-01-10 2014-11-18 Depomed, Inc. Method of managing or treating pain
US9078814B2 (en) 2003-01-10 2015-07-14 Depomed, Inc. Intranasal spray device containing pharmaceutical composition
US9814705B2 (en) 2003-01-10 2017-11-14 Depomed, Inc. Intranasal spray device containing pharmaceutical composition
JP2009073828A (ja) * 2007-08-30 2009-04-09 Taisho Pharmaceutical Co Ltd 点眼剤

Also Published As

Publication number Publication date
AU6940594A (en) 1994-12-20
CA2164113A1 (en) 1994-12-08
WO1994027578A1 (en) 1994-12-08
EP0706372A1 (de) 1996-04-17
SE9301877D0 (sv) 1993-06-02

Similar Documents

Publication Publication Date Title
KR940000229B1 (ko) 생리학적 액체와 접촉하여 겔화되는 약제학적 조성물의 제조방법
JP3181912B2 (ja) 可逆ゲル化組成物および使用方法
US5106615A (en) Eyedrops having non-newtonian rheological properties
US4136178A (en) Locust bean gum therapeutic compositions
Zimmer et al. Evaluation of pilocarpine-loaded albumin particles as controlled drug delivery systems for the eye. II. Co-administration with bioadhesive and viscous polymers
LEMP Artificial tear solutions
US8501822B2 (en) Ophthalmic composition containing alginic acid or salt thereof
JPH11510497A (ja) Ｏ−カルボキシアルキルキトサンを含む配合物及び眼科領域での使用方法
IE69016B1 (en) Nonaqueous fluorinated drug delivery vehicle suspensions
JPS5929167B2 (ja) 眼科用液剤
Durrani et al. Influence of molecular weight and formulation pH on the precorneal clearance rate of hyaluronic acid in the rabbit eye
CN101312711B (zh) 不含右泛醇、钙离子和磷酸盐的药物组合物以及钙螯合剂和眼科相容粘度调节剂的应用
JP2005513106A (ja) ヘパリンを保有する眼薬剤
JPH08510731A (ja) 治療使用のためのその場で生成するゲル
FR2660193A1 (fr) Produit opthalmique comportant des nanocapsules, son procede de preparation et utilisation des nanocapsules.
JP2001501194A (ja) ゲル形成性医薬組成物
EP1189595A1 (de) Ophthalmische zusammensetzungen in form wässriger gele
JPH10500684A (ja) 非ステロイド系抗炎症性眼科用懸濁液剤
JPH03133936A (ja) 蛋白質ゲル状眼用賦形剤
US5200180A (en) Pharmaceutical composition for the treatment of the human eye
KR100579500B1 (ko) 글리코겐을 포함하는 안용액
JP2671381B2 (ja) 点眼剤
Rupenthal et al. Ocular drug delivery
JP2003267892A (ja) 熱ゲル化人工涙液
JPS63502270A (ja) 散瞳作用を有する眼科用医薬組成物

Legal Events

Date Code Title Description
A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20031216

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20040209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040312

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20050125